High molecular weight hyaluronic acid (HA) has been widely used with platelet-rich plasma (PRP) in regenerative medicine. This study aimed to investigate the in vitro association between HA crosslinked with 1,4-butanediol diglycidyl ether (BDDE), structured in microparticles and sponges, and PRP as...

High molecular weight hyaluronic acid (HA) has been widely used with platelet-rich plasma (PRP) in regenerative medicine. This study aimed to investigate the in vitro association between HA crosslinked with 1,4-butanediol diglycidyl ether (BDDE), structured in microparticles and sponges, and PRP as composite scaffolds for growth factor release, proliferation of human adipose-derived mesenchymal stem cells and differentiation by the osteogenic marker alkaline phosphatase. The reason for using BDDE is to increase the residence time in vivo, improve the mechanical stability of free HA (fHA) and provide a larger surface area for cell proliferation and differentiation. PRP was obtained via controlled centrifugation of whole blood and activated with autologous serum and calcium. The results showed that structuration benefited the physicochemical and mechanical properties compared to fHA. Both structures were non-cytotoxic. The release of growth factors from PRP was higher than fHA but similar to fibrin network. The effects on the proliferation of seeded mesenchymal cells were not intense. However, a remarkable activity of the osteogenic marker alkaline phosphatase was observed. We concluded that the structuration of HA provides injectable or solid formulations with better properties compared to fHA, which associated with PRP may be promising for regeneration of bone tissue

CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ

Fechado